Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 28;22(4):182-196.
doi: 10.1002/jgf2.464. eCollection 2021 Jul.

A narrative review of evidence to guide deprescribing among older adults

Kenya Ie  1   2   3 , Shuichi Aoshima  4 , Taku Yabuki  5 , Steven M Albert  3
Affiliations
Review

A narrative review of evidence to guide deprescribing among older adults

Kenya Ie et al. J Gen Fam Med. .

Abstract

Potentially inappropriate prescription and polypharmacy are well-known risk factors for morbidity and mortality among older adults. However, recent systematic reviews have failed to demonstrate the overall survival benefits of deprescribing. Thus, it is necessary to synthesize the current evidence to provide a practical direction for future research and clinical practice. This review summarizes the existing body of evidence regarding deprescribing to identify useful intervention elements. There is evidence that even simple interventions, such as direct deprescribing targeted at risky medications and explicit criteria-based approaches, effectively reduce inappropriate prescribing. On the other hand, if the goal is to improve clinical outcomes such as hospitalization and emergency department visits, patient-centered multimodal interventions such as a combination of medication review, multidisciplinary collaboration, and patient education are likely to be more effective. We also consider the opportunities and challenges for deprescribing within the Japanese healthcare system.

Keywords: Japanese healthcare system; deprescribing; intervention; older adults; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interests for this article.

References

    1. Fick D. Potentially inappropriate medication use in a medicare managed care population: Association with higher costs and utilization. J Manag Care Pharm. 2001;7(5):407–13.
    1. Mangin D, Bahat G, Golomb BA, Mallery LH, Moorhouse P, Onder G, et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position Statement and 10 Recommendations for Action. Drugs Aging. 2018;35(7):575–87. - PMC - PubMed
    1. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. J Am Med Assoc. 2005;294(6):716–24. - PubMed
    1. Chao TF, Chiang CE, Lin YJ, Chang SL, Lo LW, Hu YF, et al. Evolving changes of the use of oral anticoagulants and outcomes in patients with newly diagnosed atrial fibrillation in Taiwan. Circulation. 2018;138(14):1485–7. - PubMed
    1. Armitage J, Baigent C, Barnes E, et al. Efficacy and safety of statin therapy in older people: a meta‐analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393(10170):407–15. - PMC - PubMed

LinkOut - more resources